‘BioGlue’
for the Repair of Aortic Insufficiency in Acute Aortic Dissection
Ehud Raanani, Georgios P. Georghiou, Alex Kogan, Boniface Wandwi,
Yaron Shapira, Bernardo A. Vidne
Cardiac Suergy Department, Sheba Medical
Center, Tel Hashomer, Israel, Departments of Cardiothoracic Surgery
and Cardiology, Rabin Medical Center, Petah Tiqwa, affiliated with
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel |
Background and aim of the study: Concern has
been raised regarding the late effects of tissue glues. Herein is described
the authors’ experience with a new bioadhesive (BioGlue; Cryolife)
for repair of the aortic root in acute dissection.
Methods: BioGlue is composed of bovine serum albumin (BSA)
and glutaraldehyde. Glutaraldehyde exposure causes the lysine molecules
of BSA, extracellular proteins and cell surfaces to bind to each
other, creating a strong scaffold. Between January 2001 and January
2003, BioGlue was used to repair the aortic root in 22 patients
with acute aortic dissection. Moderate or severe insufficiency
was present in 16 cases, and mild insufficiency in six. The mechanism
of insufficiency was commissure detachment in 15 cases, penetration
of the intimal flap into the valve in three, and dilatation of
the sinotubular junction in four. The aortic valve was resuspended
to the aortic |
wall using pledgeted sutures. BioGlue was used to glue
the dissected layers of the aortic root and create stronger tissue for
sewing. Two patients required complete resection of the sinuses and aortic
root remodeling with a Dacron graft.
Results: There were two operative deaths. Postoperative
transesophageal echocardiography showed mild or no aortic insufficiency
in 18 patients, and moderate insufficiency in two. During follow
up (mean 16 months), none of the patients required reoperation
for proximal redissection, delayed rupture, or aortic insufficiency.
Conclusion: BioGlue is useful for aortic valve repair
in aortic dissection. It is less toxic and has a stronger adhesive
effect than the older surgical glues, and is expected to have better
long-term results.
The Journal of Heart Valve Disease 2004;13:734-737 |